|
Religare Enterprises Limited (Religare.NS) DCF -Bewertung
IN | Financial Services | Financial - Capital Markets | NSE
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Religare Enterprises Limited (RELIGARE.NS) Bundle
Möchten Sie den inneren Wert von Religare Enterprises Limited beurteilen? Unser (Religarens) DCF-Taschenrechner integriert reale Daten mit umfangreichen Anpassungsfunktionen, sodass Sie Ihre Prognosen verfeinern und Ihre Anlagestrategien verbessern können.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11,802.9 | 16,814.2 | 22,794.8 | 37,253.7 | 50,446.6 | 72,753.1 | 104,922.9 | 151,317.6 | 218,227.1 | 314,722.5 |
| Revenue Growth, % | 0 | 42.46 | 35.57 | 63.43 | 35.41 | 44.22 | 44.22 | 44.22 | 44.22 | 44.22 |
| EBITDA | .0 | 3,122.2 | -3,496.9 | .0 | 4,189.0 | 1,677.9 | 2,419.9 | 3,489.9 | 5,033.1 | 7,258.6 |
| EBITDA, % | 0 | 18.57 | -15.34 | 0 | 8.3 | 2.31 | 2.31 | 2.31 | 2.31 | 2.31 |
| Depreciation | 20,295.3 | 22,517.2 | 36,179.7 | 42,262.3 | 717.0 | 58,409.3 | 84,236.6 | 121,484.3 | 175,202.0 | 252,672.7 |
| Depreciation, % | 171.95 | 133.92 | 158.72 | 113.44 | 1.42 | 80.28 | 80.28 | 80.28 | 80.28 | 80.28 |
| EBIT | -20,295.3 | -19,395.0 | -39,676.5 | -42,262.3 | 3,471.9 | -57,201.0 | -82,494.1 | -118,971.3 | -171,577.8 | -247,445.9 |
| EBIT, % | -171.95 | -115.35 | -174.06 | -113.44 | 6.88 | -78.62 | -78.62 | -78.62 | -78.62 | -78.62 |
| Total Cash | 15,147.4 | 16,200.0 | 25,259.8 | 8,115.9 | 10,721.7 | 49,382.8 | 71,218.8 | 102,710.2 | 148,126.5 | 213,624.8 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1,993.4 | 10,934.9 | 15,080.3 | 1,754.5 | 2,451.9 | 22,939.0 | 33,082.1 | 47,710.3 | 68,806.8 | 99,231.7 |
| Account Receivables, % | 16.89 | 65.03 | 66.16 | 4.71 | 4.86 | 31.53 | 31.53 | 31.53 | 31.53 | 31.53 |
| Inventories | 4.7 | 5.0 | 5.4 | 3.3 | .0 | 14.8 | 21.4 | 30.8 | 44.5 | 64.2 |
| Inventories, % | 0.03943101 | 0.02970109 | 0.02388701 | 0.00890649 | 0 | 0.02038512 | 0.02038512 | 0.02038512 | 0.02038512 | 0.02038512 |
| Accounts Payable | 6,218.3 | 11,289.1 | 18,750.4 | 3,187.0 | 7,896.6 | 32,926.6 | 47,486.1 | 68,483.4 | 98,765.3 | 142,437.3 |
| Accounts Payable, % | 52.68 | 67.14 | 82.26 | 8.55 | 15.65 | 45.26 | 45.26 | 45.26 | 45.26 | 45.26 |
| Capital Expenditure | -249.2 | -197.3 | -396.1 | -404.0 | -214.1 | -950.4 | -1,370.6 | -1,976.7 | -2,850.8 | -4,111.3 |
| Capital Expenditure, % | -2.11 | -1.17 | -1.74 | -1.08 | -0.42437 | -1.31 | -1.31 | -1.31 | -1.31 | -1.31 |
| Tax Rate, % | 47.97 | 47.97 | 47.97 | 47.97 | 47.97 | 47.97 | 47.97 | 47.97 | 47.97 | 47.97 |
| EBITAT | -18,371.5 | -19,823.9 | -59,410.4 | -39,967.4 | 1,806.3 | -50,007.0 | -72,119.0 | -104,008.5 | -149,998.9 | -216,325.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 5,894.9 | -1,375.2 | -20,311.4 | -344.6 | 6,324.7 | 11,980.1 | 15,156.7 | 21,858.7 | 31,524.2 | 45,463.5 |
| WACC, % | 7.44 | 7.55 | 7.55 | 7.49 | 6.99 | 7.41 | 7.41 | 7.41 | 7.41 | 7.41 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 97,426.8 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 46,373 | |||||||||
| Terminal Value | 857,687 | |||||||||
| Present Terminal Value | 600,028 | |||||||||
| Enterprise Value | 697,455 | |||||||||
| Net Debt | -6,296 | |||||||||
| Equity Value | 703,751 | |||||||||
| Diluted Shares Outstanding, MM | 329 | |||||||||
| Equity Value Per Share | 2,139.79 |
What You Will Receive
- Real RELIGARENS Financial Data: Pre-loaded with Religare Enterprises Limited's historical and projected data for accurate analysis.
- Fully Customizable Template: Easily adjust key inputs like revenue growth, WACC, and EBITDA percentage.
- Instant Calculations: Watch Religare's intrinsic value update in real-time as you make adjustments.
- Professional Valuation Tool: Tailored for investors, analysts, and consultants who need precise DCF results.
- User-Friendly Interface: Clear structure and easy-to-follow instructions suitable for all levels of expertise.
Key Features
- 🔍 Real-Life RELIGARENS Financials: Pre-filled historical and projected data for Religare Enterprises Limited.
- ✏️ Fully Customizable Inputs: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Integrated formulas assess Religare’s intrinsic value using the Discounted Cash Flow approach.
- ⚡ Instant Results: View Religare’s valuation in real-time after making adjustments.
- Scenario Analysis: Examine and compare outcomes for different financial assumptions side-by-side.
How It Works
- Download the Template: Get instant access to the Excel-based RELIGARENS DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically refreshes the intrinsic value of Religare Enterprises Limited.
- Test Scenarios: Experiment with different assumptions to assess potential valuation shifts.
- Analyze and Decide: Leverage the outcomes to inform your investment or financial decisions.
Why Opt for This Calculator?
- All-in-One Solution: Integrates DCF, WACC, and financial ratio analyses for a comprehensive experience.
- Tailored Inputs: Modify the yellow-highlighted fields to explore different scenarios.
- In-Depth Analysis: Automatically computes Religare Enterprises Limited's intrinsic value and Net Present Value.
- Preloaded Information: Access historical and projected data for reliable starting points.
- Professional Grade: Perfect for financial analysts, investors, and business consultants.
Who Can Benefit from This Product?
- Investors: Accurately assess the fair value of Religare Enterprises Limited (RELIGARENS) prior to making investment decisions.
- CFOs: Utilize a professional-grade DCF model for comprehensive financial reporting and analysis.
- Consultants: Efficiently customize the template for valuation reports tailored to clients.
- Entrepreneurs: Acquire insights into financial modeling practices employed by leading firms.
- Educators: Employ it as a teaching resource to illustrate various valuation methodologies.
Overview of the Template Contents
- Operating and Balance Sheet Data: Pre-populated historical data and forecasts for Religare Enterprises Limited (RELIGARENS), including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for calculating the Weighted Average Cost of Capital (WACC), featuring key parameters such as Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Customizable Discounted Cash Flow models that present intrinsic value with comprehensive calculations.
- Financial Statements: Pre-included financial statements (annual and quarterly) to facilitate thorough analysis.
- Key Ratios: A collection of profitability, leverage, and efficiency ratios pertinent to Religare Enterprises Limited (RELIGARENS).
- Dashboard and Charts: A visual overview of valuation outputs and underlying assumptions to simplify the analysis of results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.